https://gsk2879552inhibitor.co....m/surgery-in-order-t
Quality control for individual induced pluripotent stem cells (hiPSCs) is essential for efficient and stable production of hiPSC-derived cell therapy products to be utilized for transplantation. During cellular culture, hiPSCs spontaneously go through morphological changes and drop pluripotent properties. Such cells are termed deviated cells, which are changed from the undifferentiated condition of hiPSCs, and show early differentiation marker stage-specific embryonic antigen 1